STIMULATE-ICP ( Long Covid Study)


Senior Member
The STIMULATE-ICP ( will be a 2-year study, starting on the fall, investigating causes and treatments for Long Covid.

It seems they are looking into three different treatments to trial:
* anticoagulant rivaroxaban;
* anti-inflammatory drug colchicine;
* antihistamine combination of famotidine and loratadine;

The only treatment I have not heard about is Rivaroxaban. Any thoughts on that? I heard about other anti-coagulants being used in CFS patients though.